PRKDC mutations in a SCID patient with profound neurological abnormalities
Lisa Woodbine1, Jessica A Neal, Nanda-Kumar Sasi
1Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom.
The Journal of Clinical Investigation
|June 1, 2013
Summary
DNA-PKcs deficiency causes severe SCID and unexpected neurological impairment in humans, unlike in animal models. This highlights DNA-PKcs
Area of Science:
- Genetics and Molecular Biology
- Immunology
- Neuroscience
Background:
- DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is crucial for DNA double-strand break repair via non-homologous end-joining (NHEJ).
- NHEJ is essential for V(D)J recombination during lymphocyte development.
Observation:
- A patient with compound heterozygous PRKDC mutations exhibited low DNA-PKcs expression, reduced kinase activity, and impaired DNA repair.
- The patient presented with severe combined immunodeficiency (SCID), dysmorphic features, microcephaly, seizures, and profound neurological dysfunction.
- MRI revealed cortical and hippocampal dysplasia and progressive brain atrophy, more severe than in other NHEJ-deficient individuals.
Findings:
- One PRKDC mutation fully inactivated DNA-PKcs, while the other conferred significantly diminished residual function.
- Human neuronal development, unlike in animal models, showed a stringent requirement for DNA-PKcs.
- High DNA-PKcs expression appears necessary for efficient prenatal and postnatal neurogenesis.
Implications:
- This study identifies a critical role for DNA-PKcs in human neurodevelopment, diverging from findings in animal models.
- It suggests potential therapeutic targets for neurodevelopmental disorders linked to DNA repair pathways.
- The research underscores the importance of species-specific differences in understanding genetic disease mechanisms.


